surgical site infection, antibiotic prophylaxis, gynecologic malignancy
endometrial cancer, port site metastases, cancer recurrence
novel biomarkersprogestin-based therapyendometrial intraepithelial neoplasia
EIN, pre-menopausal, biomarkers, fertility-sparing treatment
cervical cancer, Pembrolizumab